A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study

[1]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[2]  O. Levina,et al.  Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla‐Järve, Estonia , 2017, Addiction.

[3]  T. Finlayson,et al.  Antiretroviral Therapy Use Among HIV-Infected People Who Inject Drugs—20 Cities, United States, 2009–2015 , 2017, Journal of acquired immune deficiency syndromes.

[4]  A. Pharris,et al.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens , 2017, The Journal of infectious diseases.

[5]  C. Latkin,et al.  Increased Survival Among HIV-Infected PWID Receiving a Multi-Level HIV Risk and Stigma Reduction Intervention: Results From a Randomized Controlled Trial , 2017, Journal of acquired immune deficiency syndromes.

[6]  Julio S. G. Montaner,et al.  Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996–2014: A Prospective Cohort Study , 2017, The Journal of infectious diseases.

[7]  T. Neilands,et al.  A Strengths-Based Case Management Intervention to Reduce HIV Viral Load Among People Who Use Drugs , 2017, AIDS and Behavior.

[8]  M. Tyndall,et al.  Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study , 2016, PloS one.

[9]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[10]  B. Lau,et al.  The Effect of a Multi-Level Intervention on the Initiation of Antiretroviral Therapy (ART) among HIV-Infected Men Who Inject Drugs and Were Diagnosed Late in Thai Nguyen, Vietnam , 2016, PloS one.

[11]  K. Looker,et al.  Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Jessie K. Edwards,et al.  A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU , 2016, AIDS.

[13]  J. Montaner,et al.  Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting , 2016, AIDS.

[14]  N. El-Bassel,et al.  The HIV Epidemic in Eastern Europe and Central Asia , 2014, Current HIV/AIDS Reports.

[15]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[16]  S. Strathdee,et al.  Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward. , 2013, Drug and alcohol dependence.

[17]  O. Neduzhko,et al.  Association of injecting drug use and late enrolment in HIV medical care in Odessa Region, Ukraine , 2013, HIV medicine.

[18]  C. Beyrer,et al.  The changing epidemiology of HIV in 2013 , 2013, Current opinion in HIV and AIDS.

[19]  C. Bucello,et al.  Mortality among people who inject drugs: a systematic review and meta-analysis. , 2013, Bulletin of the World Health Organization.

[20]  T. Rhodes,et al.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy , 2012, BMJ Open.

[21]  S. Shoptaw,et al.  Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention , 2012, Current opinion in HIV and AIDS.

[22]  M. Pollack,et al.  Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. , 2012, Journal of consulting and clinical psychology.

[23]  A. Lansky,et al.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[24]  Jason Fine,et al.  Competing Risks Regression for Stratified Data , 2011, Biometrics.

[25]  D. Celentano,et al.  Mortality and HIV transmission among male Vietnamese injection drug users. , 2011, Addiction.

[26]  C. Beyrer,et al.  Time to act: a call for comprehensive responses to HIV in people who use drugs , 2010, The Lancet.

[27]  Crime.,et al.  WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.. , 2009 .

[28]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.